The UA-induced NF-κB activation in skin melanoma cells was relatively sustained in response to mTOR inhibition, suggesting that both AKT and the AKT-activated mTOR exert regulatory effects on PGC-1α expression. The gene discussed is PPARGC1A; the disease is cutaneous melanoma.